|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,964.00 INR | +0.03% |
|
-0.49% | +14.21% |
| 07-31 | Sun Pharmaceutical Industries Limited, Q1 2027 Earnings Call, Jul 31, 2026 | |
| 07-31 | Sun Pharmaceutical's Consolidated Net Profit Grows in Fiscal Q1 | MT |
| Market Cap | 4,712B 49.54B 43.01B 40.11B 36.84B 69.68B 70.44B 473B 185B 2,356B 186B 182B 7,805B | P/E 2027 * |
36x | P/E 2028 * | 30.5x |
|---|---|---|---|---|---|
| Enterprise Value | 4,433B 46.61B 40.47B 37.73B 34.66B 65.55B 66.27B 445B 174B 2,216B 175B 171B 7,343B | EV / Sales 2027 * |
6.81x | EV / Sales 2028 * | 5.99x |
| Free-Float |
44.39% | Yield 2027 * |
0.86% | Yield 2028 * | 0.99% |
Last Transcript: Sun Pharmaceutical Industries Ltd.
| 1 day | +0.03% | ||
| 1 week | -0.49% | ||
| Current month | -1.33% | ||
| 1 month | +3.11% | ||
| 3 months | +8.61% | ||
| 6 months | +15.39% | ||
| Current year | +14.21% |
| 1 week | 1,935.2 |  | 2,046.9 |
| 1 month | 1,875.1 | | 2,046.9 |
| Current year | 1,583.7 | | 2,046.9 |
| 1 year | 1,548 | | 2,046.9 |
| 3 years | 1,068.35 | | 2,046.9 |
| 5 years | 733.7 | | 2,046.9 |
| 10 years | 312 | | 2,046.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Aalok Shanghvi
CEO | Chief Executive Officer | - | - |
| Chief Executive Officer | 59 | 01/09/2025 | |
| Director of Finance/CFO | 58 | 01/07/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | - | |
| Director/Board Member | 59 | 01/09/2025 | |
| Director/Board Member | 73 | 25/05/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.03% | -0.49% | +20.51% | +72.13% | 49.43B | |
| +4.48% | +6.09% | +61.10% | +128.42% | 38.54B | |
| -0.98% | +3.59% | -2.85% | +25.23% | 12.5B | |
| +0.80% | +1.97% | +19.07% | +76.56% | 11.73B | |
| +2.50% | -0.57% | +30.73% | +130.67% | 9.09B | |
| -1.30% | -5.43% | +40.59% | -13.01% | 7.01B | |
| +0.17% | +2.31% | +15.24% | +34.04% | 6.86B | |
| -0.22% | +1.32% | +7.60% | +180.88% | 6.6B | |
| +2.65% | +2.28% | -33.70% | +9.41% | 5.48B | |
| +0.32% | +4.11% | +30.79% | +104.76% | 4.6B | |
| Average | +0.85% | +1.20% | +18.91% | +74.91% | 15.18B | |
| Weighted average by Cap. | +1.32% | +0.83% | +27.87% | +84.21% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 651B 6.84B 5.94B 5.54B 5.09B 9.63B 9.73B 65.32B 25.54B 325B 25.7B 25.14B 1,078B | 729B 7.66B 6.65B 6.2B 5.7B 10.78B 10.9B 73.13B 28.59B 364B 28.77B 28.14B 1,207B |
| Net income | 131B 1.38B 1.2B 1.11B 1.02B 1.94B 1.96B 13.14B 5.14B 65.45B 5.17B 5.06B 217B | 155B 1.63B 1.42B 1.32B 1.21B 2.29B 2.32B 15.55B 6.08B 77.49B 6.12B 5.99B 257B |
| Net Debt | -279B -2.93B -2.55B -2.37B -2.18B -4.13B -4.17B -28B -10.95B -139B -11.02B -10.77B -462B | -349B -3.67B -3.19B -2.97B -2.73B -5.16B -5.22B -35.04B -13.7B -175B -13.78B -13.48B -578B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/08/26 | ₹1,964.00 | +0.03% | 1,452,888 |
| 03/08/26 | ₹1,963.50 | -1.36% | 3,972,351 |
| 31/07/26 | ₹1,990.50 | -0.53% | 4,954,449 |
| 30/07/26 | ₹2,001.10 | +0.56% | 2,224,264 |
| 29/07/26 | ₹1,989.90 | +0.67% | 2,682,295 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SUNPHARMA Stock
Select your edition
All financial news and data tailored to specific country editions
